Sterilization is a term referring to any process that eliminates (removes) or kills all forms of microbial life, including transmissible agents (such as fungi, bacteria, viruses, spore forms, etc.) present on a surface, contained in a fluid, in medication, or in a compound such as biological culture media. Sterilization can be achieved by applying the proper combinations of heat, chemicals, irradiation, high pressure, and filtration. Sterile Products are dosage forms of therapeutic agents that are free of viable microorganisms. Sterile products are most frequently solution or suspensions, but may even be solid pellets for tissue implementation. The most frequently used vehicle for sterile products is water since it is the vehicle for all body products. Sterile water is water that has no microorganisms living within it. As it cannot transfer pathogens, it is used mainly in the medical setting. Sterile water, though sometimes distilled, is not the same thing as distilled water. As some microorganisms can survive at high temperatures, simply boiling water may not be enough to sterilize it. Special, but not uncommon, equipment is required if one wishes to sterilize water. Uses and Applications Sterile Water for Injection is indicated for use only as a solvent or diluents vehicle for parenterally administered drugs or solutions and as a source of water for parenteral fluid replenishment after suitable additives are introduced to avoid tonicity of the blood. In some cases, it may be used as a lavage or rinsing agent, but isotonic solutions suitable to the area of exposure are preferred if available. When administered intravenously as a vehicle for drugs, Sterile Water for Injection provides a source of water for parenteral fluid replenishment after proper osmolarity has been achieved. The osmolarity of the solution determines the direction of water flow into or out of the cell. In normal body situations, solute concentration within and outside the cell is isotonic. Market Survey Intravenous fluids injected into a patientâ€™s vein either as a medium for other medicines or to relieve dehydration may soon get costlier as the drug price regulator is considering an upward revision in their pricesâ€”for the first time in eleven years. Four-fifths of patients admitted to a hospital require intravenous fluids regularly, making it an essential part of treatment as well as the hospital bill, according to medical practitioners. Intravenous fluids have a big market with an annual turnover of more than Rs 400 crore, which is growing at about 14% a year due to its essential nature. Some of the Asian countries are changing and becoming very competitive in biopharma manufacturing. Few Major Players are as under:- Albert David Ltd. Core Laboratories Ltd. [Merged] Lupin Laboratories Ltd. [Merged] Pure Pharma Ltd. Taulis Pharma Ltd.